Aldosterone: Secretion and Action

Endocrinology: Adult and Pediatric, Sixth Edition

Volumn 2, Issue , 2010, Pages 1831-1838

  Fuller, Peter ^a,b,c  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b Southern Health   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80355136221     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-5583-9.00099-X     Document Type: Chapter

References (139)

1. GP Vinson, BJ Whitehouse, C Goddard, et al. (1979) Comparative and evolutionary aspects of aldosterone secretion and zona glomerulosa function. J Endocrinol 81 5P-24P.
2. FM Rogerson and PJ Fuller (2000) Mineralocorticoid action. Steroids 65 61-73.
3. SA Simpson, JF Tait, A Wettstein, et al. (1953) Isolierung eines neuen kristallisierten Hormons aus Nebennieren mit besonders hoher Wirksamkeit auf den Mineral-stoffwechsel. Experientia 9 333-335.
4. J Crabbè (1961) Stimulation of active sodium transport across toad bladder with aldosterone in vitro. J Clin Invest 76 2103-2110.
5. D Feldman, JW Funder and IS Edelman (1972) Subcellular mechanisms in the action of adrenal steroids. Am J Med 53 545-560.
6. MR Weir and VJ Dzau (1999) The renin-angiotensin-aldosterone system: a specific target: hypertension management. Am J Hypertens 12 205S-213S.
7. EF Nogueira, CA Vargas, M Otis, et al. (2007) Angiotensin-II acute regulation of rapid response genes in human, bovine, and rat adrenocortical cells. J Mol Endocrinol 39 365-374.
8. S Okubo, F Niimura, H Nishimura, et al. (1997) Angiotensin-independent mechanism for aldosterone synthesis during chronic extracellular fluid volume depletion. J Clin Invest 99 855-860.
9. RM Carey (1995) Physiologic and possible pathophysiologic relevance of dopaminergic mechanisms in the control of aldosterone secretion. F Mantero, EG Biglieri, JW Funder, BA Scoggins,(Eds) The Adrenal and Hypertension New York: Raven 55-69.
10. NK Hollenberg, WR Chenitz, DF Adams, et al. (1974) Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man. J Clin Invest 54 34-42.
11. F Knox, JJ Burnett, D Kohan, et al. (1980) Escape from the sodium-retaining effects of mineralocorticoids. Kidney Int 17 263-276.
12. RS Zimmerman, BS Edwards, TR Schwab, et al. (1987) Atrial natriuretic peptide during mineralocorticoid escape in the human. J Clin Endocrinol Metab 64 624-627.
13. CA Gaillard, HA Koomans, TJ Rabelink, et al. (1988) Enhanced natriuretic effect of atrial natriuretic factor during mineralocorticoid escape in humans. Hypertension 12 450-456.
14. P Ye, CJ Kenyon, SM MacKenzie, et al. (2005) The aldosterone synthase (CYP11B2) and 11β-hydroxylase (CYP11B1) genes are not expressed in the rat heart. Endocrinology 146 5287-5293.
15. DB Young (1988) Quantitative analysis of aldosterone's role in potassium regulation. Am J Physiol 55 F811-F822.
16. GH Williams, LI Rose, RG Dluhy, et al. (1971) Aldosterone response to sodium restriction and ACTH stimulation in panhypopituitarism. J Clin Endocrinol Metab 32 27-35.
17. G Rousseau, JD Baxter, JW Funder, et al. (1972) Glucocorticoid and mineralocorticoid receptors for aldosterone. J Steroid Biochem 3 219-227.
18. JW Funder, D Feldman and IS Edelman (1972) Specific aldosterone binding in rat kidney and parotid. J Steroid Biochem 3 209-218.
19. D Marver, J Stewart, JW Funder, et al. (1974) Renal aldosterone receptors: studies with (3H)aldosterone and the anti-mineralocorticoid (3H)spirolactone (SC-26304). Proc Natl Acad Sci U S A 71 1431-1435.
20. JL Arriza, C Weinberger, G Cerelli, et al. (1987) Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237 268-275.
21. PD Patel, TG Sherman and DJ Goldman (1989) Molecular cloning of a mineralocorticoid (type I) receptor complementary DNA for rat hippocampus. Mol Endocrinol 3 1877-1885.
22. MD Todd-Turla, J Schnermann, G Fejes-Toth, et al. (1993) Distribution of mineralocorticoid glucocorticoid receptor mRNA along the nephron. Am J Physiol 264 F781-F791.
23. PJ Fuller and K Verity (1990) Mineralocorticoid receptor gene expression in the gastrointestinal tract: distribution and ontogeny. J Steroid Biochem 36 263-267.
24. DJ Mangelsdorf, C Thummel, M Beato, et al. (1995) The nuclear receptor superfamily: the second decade. Cell 83 835-839.
25. Y-S Fan, RL Eddy, LL Byers, et al. (1989) The human mineralocorticoid receptor gene (MLR) is located on chromosome 4 at q31.2. Cytogenet Cell Genet 52 83-84.
26. A Theriault, E Boyd, SB Harrap, et al. (1989) Regional chromosomal assignment of the human glucocorticoid receptor gene to 5q31. Hum Genet 83 289-291.
27. BF Luisi, WX Xu, Z Itwubiwsju, et al. (1991) Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352 497-505.
28. J Fagart, J Huyet, GM Pinon, et al. (2005) Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension. Nature Struct Mol Biol 12 554-555.
29. R.K. Bledsoe, KP Madauss, JA Holt, et al. (2005) A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor. J Biol Chem 280 31283-31293.
30. Y Li, K Suino, J Daugherty, et al. (2005) Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor. Mol Cell 19 367-380.
31. FM Rogerson and PJ Fuller (2003) Interdomain interactions in the mineralocorticoid receptor. Mol Cell Endocrinol 200 45-55.
32. A Odermatt, P Arnold and FJ Frey (2001) The intracellular localization of the mineralocorticoid receptor is regulated by 11beta-hydroxysteroid dehydrogenase type 2. J Biol Chem 276 28484-28492.
33. KL Bruner, A Derfoul, NM Robertson, et al. (1997) The unliganded mineralocorticoid receptor is associated with heat shock proteins 70 and 90 and the immunophilin FKBP-52. Recept Signal Transduct 7 85-98.
34. PJ Fuller and MJ Young (2005) Mechanisms of mineralocorticoid action. Hypertension 46 1227-1235.
35. FM Rogerson, YZ Yao, BJ Smith, et al. (2003) Determinants of spironolactone binding specificity in the mineralocorticoid receptor. J Mol Endocrinol 31 573-582.
36. S Viengchareun, D Le Menuet, L Martinerie, et al. (2007) The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology. Nucl Recept Signal 5 1-16.
37. ZS Krozowski and JW Funder (1983) Renal mineralocorticoid receptors and hippocampal corticosterone binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci U S A 80 6056-6060.
38. ER de Kloet, E Vreugdenhil, MS Oitzl, et al. (1998) Brain corticosteroid receptor balance in health and disease. Endocr Rev 19 269-301.
39. SP Kwak, PD Patel, RC Thompson, et al. (1993) 5′-heterogeneity of the mineralocorticoid receptors messenger ribonucleic acid: differential expression and regulation of splice variants within the rat hippocampus. Endocrinology 133 2344-2350.
40. M-C Zennaro, MC Keightley, Y Kotelevtsev, et al. (1995) Human mineralocorticoid receptor genomic structure and identification of expressed isoforms. J Biol Chem 270 21016-21020.
41. M-C Zennaro, D Le Menuet and M Lombes (1996) Characterization of the human mineralocorticoid receptor gene 5′-regulatory region: evidence for differential hormonal regulation of two alternative promoters via non-classical mechanisms. Mol Endocrinol 10 1549-1560.
42. MC Zennaro, A Souque, S Viengchareun, et al. (2001) A new human MR splice variant is a ligand-independent transactivator modulating corticosteroid action. Mol Endocrinol 15 1586-1598.
43. B Couette, J Fagart, S Jalaguier, et al. (1996) Ligand-induced conformational change in the human mineralocorticoid receptor occurs within its hetero-oligomeric structure. Biochem J 315 421-427.
44. N Farman and ME Rafestin-Oblin (2001) Multiple aspects of mineralocorticoid selectivity. Am J Physiol Renal Physiol 280 F181-F192.
45. SS Lim-Tio, M-C Keightley and PJ Fuller (1997) Determination of specificity of transactivation by the mineralocorticoid or glucocorticoid receptors. Endocrinology 138 2537-3543.
46. A Naray-Fejes-Toth and G Fejes-Toth (1990) Glucocorticoid receptors mediate mineralocorticoid-like effects in cultured collecting duct cells. Am J Physiol 259 F672-F678.
47. D Pearce and KR Yamamoto (1993) Mineralocorticoid and glucocorticoid receptor activities are distinguished by nonreceptor factors at a composite response element. Science 259 1661-1665.
48. SS Lim-Tio and PJ Fuller (1998) Intracellular signaling pathways confer specificity of transactivation by mineralocorticoid and glucocorticoid receptors. Endocrinology 139 1653-1661.
49. EP Gomez-Sanchez, MT Venkataraman, D Thwaites, et al. (1990) Intracerebroventricular infusion of corticosterone antagonizes ICV-aldosterone hypertension. Am J Physiol 258 E649-E653.
50. JW Funder, P Pearce, K Myles, et al. (1990) Apparent mineralocorticoid excess, pseudohypoaldosteronism and urinary electrolyte excretion: towards a redefinition of “mineralocorticoid” action. FASEB J 4 3234-3238.
51. MJ Young and JW Funder (2002) Mineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular system. J Hypertens 20 1465-1468.
52. B Pitt, F Zannad, WJ Remme, et al. (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341 709-717.
53. B Pitt, W Remme, F Zannad, et al. (2003) Eplerenone post-acute myocardial infarction heart failure efficacy and survival study investigators. N Engl J Med 348 1309-1321.
54. S Berger, M Bleich, W Schmid, et al. (1998) Mineralocorticoid receptor knockout mice: pathophysiology of Na+ metabolism. Proc Natl Acad Sci U S A 95 9424-9429.
55. DS Geller, J Rodriguez-Soriano, AV Boado, et al. (1998) Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type 1. Nat Genet 19 279-281.
56. L Pujo, J Fagart, F Gary, et al. (2007) Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism. Hum Mutat 28 33-40.
57. DS Geller, J Zhang, MC Zennaro, et al. (2006) Autosomal dominant pseudohypoaldosteronism type 1: mechanisms, evidence for neonatal lethality, and phenotypic expression in adults. J Am Soc Nephrol 16 1429-1436.
58. RM Losel, M Feuring, E Falkenstein, et al. (2002) Nongenomic effects of aldosterone: cellular aspects and clinical implications. Steroids 67 493-498.
59. JW Funder (2005) The nongenomic actions of aldosterone. Endocr Rev 26 313-321.
60. C Grossmann, R Freudinger, S Mildenbergr, et al. (2008) EF-domains are sufficient for nongenomic mineralocorticoid receptor actions. J Biol Chem 283 7109-7116.
61. V McEneaney, BJ Harvey and W Thomas (2008) Aldosterone regulates rapid trafficking of ENaC subunits in renal cortical collecting duct cells via protein kinase D activation. Mol Endocrinol 22 881-882.
62. AS Mihailidou, M Mardini and JW Funder (2003) Rapid, nongenomic effects of aldosterone in the heart mediated by epsilon protein kinase C. Endocrinology 145 773-780.
63. R Alzamora, ET Marusic, M Gonzalez, et al. (2003) Nongenomic effect of aldosterone on Na+,K+-adenosine triphosphatase in arterial vessels. Endocrinology 144 1266-1272.
64. H Karst, S Berger, M Turiault, et al. (2005) Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glucamate transmission by corticosterone. Proc Natl Acad Sci U S A 102 19204-19207.
65. M Joels, H Karst, R DeRijk, et al. (2008) The coming out of the brain mineralocorticoid receptor. Trends Neurosci 31 1-7.
66. K Sheppard and JW Funder (1987) Type I receptors in parotid, colon and pituitary are aldosterone-selective in vivo. Am J Physiol 253 E467-E471.
67. BR Walker, JC Campbell, R Fraser, et al. (1992) Mineralocorticoid excess and inhibition of 11β-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Clin Endocrinol 37 483-489.
68. AK Agarwal, C Monder, B Eckstein, et al. (1989) Cloning and expression of rat cDNA encoding corticosteroid 11β-dehydrogenase. J Biol Chem 264 18939-18943.
69. GM Tannin, AK Agarwal, C Monder, et al. (1991) The human gene for 11β-hydroxysteroid dehydrogenase: Structure, tissue distribution, and chromosomal localization. J Biol Chem 266 16653-16658.
70. C Monder and V Lakshmi (1990) Corticosteroid 11β-dehydrogenase of rat tissues: immunological studies. Endocrinology 126 2435-2443.
71. AL Albiston, VR Obeyesekere, RE Smith, et al. (1994) Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 105 R11-R17.
72. M Quinkler and PM Stewart (2003) Hypertension and the cortisol-cortisone shuttle. J Clin Endocrinol Metab 88 2384-2392.
73. PC White, T Mune and AK Agarwal (1997) 11β-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev 18 135-156.
74. RE Smith, KXZ Li, RK Andrews, et al. (1997) Immunohistochemical and molecular characterization of the rat 11 beta-hydroxysteroid dehydrogenase type II enzyme. Endocrinology 138 540-547.
75. BL Roland, KX Li and JW Funder (1995) Hybridization histochemical localization of 11 beta-hydroxysteroid dehydrogenase type 2 in rat brain. Endocrinology 136 4697-4700.
76. Y Kotelevtsev, RW Brown, S Fleming, et al. (1999) Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2. J Clin Invest 103 683-689.
77. RC Wilson, S Nimkarn and MI New (2001) Apparent mineralocorticoid excess. Trends Endocrinol Metab 12 104-111.
78. PM Stewart, R Valentino, AM Wallace, et al. (1987) Mineralocorticoid activity of licorice: 11β-hydroxysteroid dehydrogenase activity comes of age. Lancet 2 821-824.
79. RC Wilson, ZS Krozowski, VR Obeyesekere, et al. (1995) A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 80 2263-2266.
80. T Mune, FM Rogerson, H Nikkila, et al. (1995) Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nat Genet 10 394-399.
81. CRW Edwards, PM Stewart, D Burt, et al. (1988) Localization of 11β-hydroxysteroid dehydrogenase: tissue-specific protector of the mineralocorticoid receptor. Lancet 2 986-989.
82. JW Funder, PT Pearce, R Smith, et al. (1988) Mineralocorticoid action: target-tissue specificity is enzyme, not receptor-mediated. Science 242 583-585.
83. F Verrey (1999) Early aldosterone action: toward filling the gap between transcription and transport. Am J Physiol 277 F319-F327.
84. JD Stockand (2002) New ideas about aldosterone signalling in epithelia. Am J Physiol 282 F559-F576.
85. BS McEwen, LT Lambdin, TC Rainbow, et al. (1986) Aldosterone effects on salt appetite in adrenalectomized rats. Neuroendocrinology 43 38-43.
86. R Rocha and JW Funder (2002) The pathophysiology of aldosterone in the cardiovascular system. Ann N Y Acad Sci 970 89-100.
87. JB Wade, BA Stanton, MJ Field, et al. (1990) Morphological and physiological responses to aldosterone: time course and sodium dependence. Am J Physiol 259 F88-F94.
88. H Garty and LG Palmer (1997) Epithelial sodium channels: function, structure and regulation. Physiol Rev 77 359-396.
89. DJ Benos, MS Awayda, II Ismailov, et al. (1995) Structure and function of amiloride-sensitive Na+ channels. J Membr Biol 143 1-18.
90. CM Canessa, L Schild, G Buell, et al. (1994) Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits. Nature 367 463-467.
91. J Jasti, H Furukawa, EB Gonzales, et al. (2007) Structure of acid-sensing ion channel 1 at 1.9A resolution and low pH. Nature 449 316-323.
92. P Barbry and P Hofman (1997) Molecular biology of Na+ absorption. Am J Physiol 273 G571-G585.
93. E Hummler, P Barker, J Gatzy, et al. (1996) Early death due to defective neonatal lung liquid clearance in αENaC-deficient mice. Nat Genet 12 325-328.
94. S Gründer and BC Rossier (1997) A reappraisal of aldosterone effects on the kidney: new insights provided by epithelial sodium channel cloning. Curr Opin Nephrol Hypertens 6 35-39.
95. PM Barker, MS Nguyen, JT Gatzy, et al. (1998) Role of gamma ENaC subunit in lung liquid clearance and electrolyte balance in newborn mice. Insights into perinatal adaptation and pseudohypoaldosteronism. J Clin Invest 102 1634-1640.
96. FJ McDonald, B Yang, RF Hrstka, et al. (1999) Disruption of the beta subunit of the epithelial Na+ channel in mice: hyperkalemia and neonatal death associated with a pseudohypoaldosteronism phenotype. Proc Natl Acad Sci U S A 96 1727-1731.
97. S Pradervand, PM Barker, Q Wang, et al. (1999) Salt restriction induces pseudohypoaldosteronism type 1 in mice expressing low levels of the beta-subunit of the amiloride-sensitive epithelial sodium channel. Proc Natl Acad Sci U S A 96 1732-1737.
98. SS Chang, S Grunder, A Hanukoglu, et al. (1996) Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet 12 248-253.
99. SS Strautnieks, RJ Thompson, RM Gardiner, et al. (1996) A novel splice-site mutation in the γ-subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families. Nat Genet 13 248-250.
100. RA Shimkets, DG Warnock, CM Bositis, et al. (1994) Liddle's syndrome: Heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel. Cell 79 407-414.
101. RP Lifton, AG Gharavi and DS Geller (2001) Molecular mechanisms of human hypertension. Cell 104 545-556.
102. O Staub, I Gautschi, T Ishikawa, et al. (1997) Regulation of stability and function of the epithelial Na+ channel ENaC by ubiquitination. EMBO J 16 6325-6336.
103. FM Rogerson, FE Brennan and PJ Fuller (2003) Dissecting mineralocorticoid receptor structure and function. J Steroid Biochem Mol Biol 85 389-396.
104. E Lingueglia, S Renard, R Waldmann, et al. (1994) Different homologous subunits of the amiloride-sensitive Na+ channel are differently regulated by aldosterone. J Biol Chem 269 13736-13739.
105. JB Stokes and RD Sigmund (1998) Regulation of rENaC mRNA by dietary NaC1 and steroids: organ, tissue, and steroid heterogeneity. Am J Physiol 274 C1699-C1707.
106. S Renard, N Voilley, F Bassilana, et al. (1995) Localization and regulation by steroids of the αβ and γ subunits of the amiloride-sensitive Na+ channel in colon, lung and kidney. Pflugers Arch 430 299-307.
107. C Asher, H Wald, BC Rossier, et al. (1996) Aldosterone-induced increase in the abundance of Na+ channel subunits. Am J Physiol 271 C605-C611.
108. KA Volk, RD Sigmund, PM Snyder, et al. (1995) rENaC is the predominant Na+ channel in the apical membrane of the rat renal inner medullary collecting duct. J Clin Invest 96 2748-2757.
109. DL Denault, G Fejes-Tòth and A Naray-Fejes-Tòth (1996) Aldosterone regulation of sodium channel γ-subunit mRNA in cortical collecting duct cells. Am J Physiol 271 C423-C428.
110. A May, A Puoti, H-P Gaeggeler, et al. (1997) Early effect of aldosterone on the rate of synthesis of the epithelial sodium channel α subunit in A6 renal cells. J Am Soc Nephrol 8 1813-1822.
111. SY Chen, A Bhargava, L Mastroberadino, et al. (1999) Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc Natl Acad Sci U S A 96 2514-2519.
112. A Naray-Fejes-Toth, C Canessa, ES Cleaveland, et al. (1999) sgk is an aldosterone-induced kinase in the renal collecting duct. J Biol Chem 274 16973-16978.
113. FE Brennan and PJ Fuller (2000) Rapid up-regulation of serum and glucocorticoid-regulated kinase (sgk) gene expression by corticosteroids in vivo. Mol Cell Endocrinol 30 129-136.
114. A Bhargava, MJ Fullerton, K Myles, et al. (2001) The serum- and glucocorticoid-induced kinase is a physiological mediator of aldosterone action. Endocrinology 142 1587-1594.
115. C Debonneville, SY Flores, E Kamynina, et al. (2001) Phosphorylation of Nedd4-2 by Sgk1 regulates epithelial Na+ channel cell surface expression. EMBO J 20 7052-7059.
116. PM Snyder, DR Olson and BC Thomas (2002) Serum and glucocorticoid-regulated kinase modulates Nedd4-2-mediated inhibition of the epithelial Na+ channel. J Biol Chem 277 5-8.
117. W Zhang, X Xia, MR Reisenauer, et al. (2007) Aldosterone-induced Sgk1 relieves Dot1a-Af9-mediated transcriptional repression of epithelial Na+ channel α. J Clin Invest 117 773-783.
118. P Fakitsas, G Adam, D Daidié, et al. (2007) Early aldosterone-induced gene product regulates the epithelial sodium channel by deubiquitylation. J Am Soc Nephrol 18 1084-1092.
119. J Wang, P Barbry, AC Maiyar, et al. (2001) SGK integrates insulin and mineralocorticoid regulation of epithelial sodium transport. Am J Physiol 280 F303-F313.
120. FE Brennan and PJ Fuller (2006) Mammalian K-ras2 is a corticosteroid-induced gene in vivo. Endocrinology 147 2809-2816.
121. R Soundarajan, J Wang, D Melters, et al. (2007) Differential activities of glucocorticoid-induced leucine zipper protein isoforms. J Biol Chem 282 36303-36313.
122. PJ Fuller and K Verity (1990) Colonic sodium-potassium adenosine triphosphate subunit gene expression: ontogeny and regulation by adrenocortical steroids. Endocrinology 127 32-38.
123. KJ Petty, JP Kokko and D Marver (1981) Secondary effect of aldosterone on Na-K,ATPase activity in the rabbit cortical collecting tubule. J Clin Invest 68 1514-1521.
124. SC Sansom and RG O’Neil (1985) Mineralocorticoid regulation of apical cell membrane Na+ and K+ transport of the cortical collecting duct. Am J Physiol 248 F858-F868.
125. B Attali, H Latter, N Rachamim, et al. (1995) A corticosteroid-induced gene expressing an “IsK-like” K+ channel activity in Xenopus oocytes. Proc Natl Acad Sci U S A 92 6092-6096.
126. P Beguin, G Crambert, S Guennoun, et al. (2001) CHIF, a member of the FXYD protein family, is a regulator of Na,K-ATPase distinct from the gamma-subunit. EMBO J 20 3993-4002.
127. H Wald, O Goldstein, C Asher, et al. (1996) Aldosterone induction and epithelial distribution of CHIF. Am J Physiol 271 F322-F329.
128. FE Brennan and PJ Fuller (1999) Acute regulation by corticosteroids of CHIF mRNA in the distal colon. Endocrinology 140 1213-1218.
129. FE Brennan and PJ Fuller (1999) Transcriptional control by corticosteroids of CHIF gene expression in the rat distal colon. Clin Exp Physiol Pharmacol 26 489-491.
130. DB Young (1988) Quantitative analysis of aldosterone's role in potassium regulation. Am J Physiol 255 F811-F822.
131. F Jaisser, B Escoubet, N Coutry, et al. (1996) Differential regulation of putative K+-ATPase by low-K+ diet and corticosteroids in rat distal colon and kidney. Am J Physiol 270 C679-C687.
132. Yoo D, Kim BY, Campo C, et al: Cell surface expression of the ROMK (Kir 1.1) channel is regulated by the aldosterone-induced kinase, sgk-1, and protein kinase A, J Biol Chem 278:23066–23075.
133. DK Stone, DW Seldin, JP Kokko, et al. (1983) Mineralocorticoid modulation of rabbit medullary collecting duct acidification. J Clin Invest 72 77-83.
134. M Kuwahara, S Sasaki and F Marumo (1992) Mineralocorticoids and acidosis regulate H+/HCO3 transport of intercalated cells. J Clin Invest 89 1388-1394.
135. TR Hays (1992) Mineralocorticoid modulation of apical and basolateralmembrane H+/OH-/HCO3 transport processes in the rabbit inner stripe of outer medullary collecting duct. J Clin Invest 90 1-8.
136. D Obradovic, M Tirard, ZS Nemethy, et al. (2004) DAXX, FLASH, and FAF-1 modulate mineralocorticoid and glucocorticoid receptor-mediated transcription in hippocampal cells: toward a basis for the opposite actions elicited by two nuclear receptors? Mol Pharmacol 65 761-769.
137. A Turchin, CZ Guo, GK Adler, et al. (2006) Effect of acute aldosterone administration on gene expression profile in the heart. Endocrinology 147 3183-3189.
138. G Fejes Tóth and A Náray-Fejes-Tóth (2007) Early aldosterone-regulated genes in cardiomyocytes: clues to cardiac remodeling? Endocrinology 148 1502-1510.
139. CS Rigsby, WE Cannady and AM Dorrance (2005) Aldosterone: good guy or bad guy in cerebrovascular disease? Trends Endocrinol Metab 16 401-406.